With deep learning methods revolutionizing life sciences, researchers bet on de novo proteins and cell mapping models to deliver customized precision medicines.

Virus-Disease Links Are Hard to Forge Researchers confront skepticism, conflicting results, limited funding By Douglas Steinberg If genomics is glitzy nowadays, virus research is, well, gritty. Its latest heyday, when HIV was shown to cause AIDS, only masked its true nature. Associating viruses with diseases has always been particularly difficult and labor intensive. Cause-and-effect relationships are maddeningly elusive.1 Consider the following two questions: Does infection by mouse mammary

Genetic adaptations for human brain development also make us vulnerable to Alzheimer’s disease, according to a new study.  

Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.

Common mutations in metastasized breast tumors suggest how the cancer can develop resistance to frontline drugs.

Transposons may be key players in how tumors develop and spread, but they also keep cancer at bay in some circumstances.

In a small clinical study, focusing ultrasound beams on tumors in patients’ brains helped open the blood-brain barrier to facilitate drug delivery.

George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.

Scientists are beginning to discover myriad strategies tumors use to avoid attacks by anti-cancer drugs.

Breast cancer's genetic profile calls the cancer stem cell hypothesis into question.